Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lowe

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Nature|May 29, 2020
Phase and context shape the function of composite oncogenic mutationsAlexander N Gorelick, Francisco J Sánchez-Rivera, Yanyan Cai, et al.
Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Science Translational Medicine|January 23, 2015
Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imagingStefan Harmsen, Ruimin Huang, Matthew A Wall, et al.
Cancer Immunology Research|September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer CellsElliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Nature Biotechnology|July 4, 2018
Optimized base editors enable efficient editing in cells, organoids and miceMaria Paz Zafra, Emma M Schatoff, Alyna Katti, et al.
Cancer Discovery|October 27, 2022
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor ImmunityHsuan-An Chen, Yu-Jui Ho, Riccardo Mezzadra, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Nature|August 5, 2011
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaJohannes Zuber, Junwei Shi, Eric Wang, et al.
Nature Biotechnology|February 24, 2009
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaVincent W Keng, Augusto Villanueva, Derek Y Chiang, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Nature|May 29, 2020
Phase and context shape the function of composite oncogenic mutationsAlexander N Gorelick, Francisco J Sánchez-Rivera, Yanyan Cai, et al.
Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Science Translational Medicine|January 23, 2015
Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imagingStefan Harmsen, Ruimin Huang, Matthew A Wall, et al.
Cancer Immunology Research|September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer CellsElliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Nature Biotechnology|July 4, 2018
Optimized base editors enable efficient editing in cells, organoids and miceMaria Paz Zafra, Emma M Schatoff, Alyna Katti, et al.
Cancer Discovery|October 27, 2022
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor ImmunityHsuan-An Chen, Yu-Jui Ho, Riccardo Mezzadra, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Nature|August 5, 2011
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaJohannes Zuber, Junwei Shi, Eric Wang, et al.
Nature Biotechnology|February 24, 2009
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaVincent W Keng, Augusto Villanueva, Derek Y Chiang, et al.
Pageof 33